• QbD and Inovigate launch Health to Market, a contract commercialization organization in life sciences

    Wednesday December 1st 2021

  • Lonza and Bioqube Ventures sign a framework agreement for the future development and manufacture of biologics and small molecules for Bioqube’s portfolio companies

    Tuesday November 30th 2021

  • Confo Therapeutics enters collaborative agreement with Regeneron

    Tuesday November 30th 2021

  • FIT and its 21-strong partner team go all out for more internationalization, growth and prosperity

    Thursday November 25th 2021

  • GSK and imec to collaborate on disruptive innovation in pharma

    Tuesday November 9th 2021

  • reMYND and the US NINDS Epilepsy Therapy Screening Program (ETSP) begin collaboration on epilepsy program

    Monday November 8th 2021

  • X-Pure®–by-design : Antleron-Rousselot® collaborative-development partnership

    Tuesday October 12th 2021

  • IBA and SCK CEN join forces to enable production of Actinium-225

    Wednesday September 15th 2021

  • Your news here?

  • Precirix and IFE sign clinical trial manufacturing agreement

    Monday September 13th 2021

  • Flamingo Therapeutics expands alliance with Ionis Pharmaceuticals to develop RNA-targeted therapies for oncology

    Thursday September 9th 2021

  • Precirix enters into alliance with 3P Biopharmaceuticals for the manufacturing of single domain antibodies

    Wednesday August 18th 2021


Strategic Partners